βήμα Σίγουρος δυναστεία 10.1097 fpc.0b013e3282f60aad με τον καιρό Αγνή Γκρέι Εξαγωγή
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile
Full article: Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation
Apolipoprotein E genotypes and response of plasma lipids and progression–regression of coronary atherosclerosis to lipid-lowering drug therapy | Journal of the American College of Cardiology
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation
Frontiers | Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Comparison between Atorvastatin and Rosuvastatin on Secondary Percutaneous Coronary Intervention Rate and the Risk Factors in Patients with Coronary Heart Disease | Bentham Science
Frontiers | Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy | Lipids in Health and Disease | Full Text